Pharmacia/Celltech Anti-TNF Antibody Deal Includes $50 Mil. Up Front
Pharmacia is paying $50 mil. up front for a chance to broaden its participation in the arthritis market to include Celltech's anti-TNF antibody CDP 870.
Pharmacia is paying $50 mil. up front for a chance to broaden its participation in the arthritis market to include Celltech's anti-TNF antibody CDP 870.